People have been trying to develop a vaccine to prevent respiratory syncytial virus (RSV) for more than 60 years, but recent advances in vaccine research and resulting technology, some of which were applied when developing the COVID-19 vaccines, are leading many experts to believe that a safe and efficacious RSV vaccine is on the horizon.
Four companies, GSK, Janssen, Moderna and Pfizer, are conducting advanced clinical trials on RSV vaccines.
Although people of all ages are